Search research articles
Contact Us
Filters
Showing results (61-70 of 168) with videos related to
Page
of 17
Sort By:
Transplantation and Cellular Therapy
|
November 14, 2021
Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
Timothy D Gauntner, Claudio G Brunstein, Qing Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 26, 2019
Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation
Shernan G Holtan, Lin Zhang, Todd E DeFor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 16, 2008
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor
Navneet S Majhail, Claudio G Brunstein, Marcie Tomblyn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2017
Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes
Betty K Hamilton, Lisa Rybicki, Sally Arai, et al.
Bone Marrow Transplantation
|
April 24, 2022
Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients
Divya Bhargava, Cathleen Drilling, Todd E DeFor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index
Joseph A Pidala, Betty K Hamilton, Paul J Martin, et al.
Cancer
|
November 18, 2020
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study
Mukta Arora, Yanjun Chen, Jessica Wu, et al.
Haematologica
|
September 22, 2018
Machine learning reveals chronic graft-<i>versus</i>-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies
Jocelyn S Gandelman, Michael T Byrne, Akshitkumar M Mistry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study
Saro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
JAMA Oncology
|
June 3, 2016
Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study
Mukta Arora, Can-Lan Sun, Kirsten K Ness, et al.
Page
of 17
Search research articles
Search
Showing results (61-70 of 168) with videos related to
Sort By:
Page
of 17
Transplantation and Cellular Therapy
|
November 14, 2021
Association of CD34 Cell Dose with 5-Year Overall Survival after Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Adults with Hematologic Malignancies
Timothy D Gauntner, Claudio G Brunstein, Qing Cao, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 26, 2019
Dynamic Graft-versus-Host Disease-Free, Relapse-Free Survival: Multistate Modeling of the Morbidity and Mortality of Allotransplantation
Shernan G Holtan, Lin Zhang, Todd E DeFor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
February 16, 2008
Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor
Navneet S Majhail, Claudio G Brunstein, Marcie Tomblyn, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 17, 2017
Association of Socioeconomic Status with Chronic Graft-versus-Host Disease Outcomes
Betty K Hamilton, Lisa Rybicki, Sally Arai, et al.
Bone Marrow Transplantation
|
April 24, 2022
Impact of CDC warning on co-prescribing of opioids and benzodiazepines in older allogeneic hematopoietic cell transplant recipients
Divya Bhargava, Cathleen Drilling, Todd E DeFor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 9, 2019
The Chronic Graft-versus-Host Disease Failure-Free Survival (cGVHD-FFS) Index
Joseph A Pidala, Betty K Hamilton, Paul J Martin, et al.
Cancer
|
November 18, 2020
Longitudinal trajectory of frailty in blood or marrow transplant survivors: Report from the Blood or Marrow Transplant Survivor Study
Mukta Arora, Yanjun Chen, Jessica Wu, et al.
Haematologica
|
September 22, 2018
Machine learning reveals chronic graft-<i>versus</i>-host disease phenotypes and stratifies survival after stem cell transplant for hematologic malignancies
Jocelyn S Gandelman, Michael T Byrne, Akshitkumar M Mistry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 22, 2022
Burden of Long-Term Morbidity Borne by Survivors of Acute Myeloid Leukemia Treated With Blood or Marrow Transplantation: The Results of the BMT Survivor Study
Saro H Armenian, Yanjun Chen, Lindsay Hageman, et al.
JAMA Oncology
|
June 3, 2016
Physiologic Frailty in Nonelderly Hematopoietic Cell Transplantation Patients: Results From the Bone Marrow Transplant Survivor Study
Mukta Arora, Can-Lan Sun, Kirsten K Ness, et al.
Page
of 17